Pharma inventory skyrockets 17% after launching 4 new medicines in India

The shares of this firm surged 17% after it introduced new merchandise for the market and set an bold goal of reaching Rs 1,000 crore over the subsequent 5 years. This has boosted the morale of the buyers.

Value Motion 

With a market capitalization of Rs 3,490 crore, the shares of Morepen Laboratories Ltd are at the moment buying and selling at Rs 63.7 per share, down by 37 p.c from its 52-week excessive of Rs 101 per share. Over the past one yr, the inventory has given a constructive return of 23.54 p.c.

In regards to the announcement

On Thursday, the corporate introduced a key enterprise replace, which prompted the inventory to surge 16% throughout right this moment’s buying and selling session. The corporate introduced the launch of 4 new merchandise out there, specifically Ticapen, UdoFix, LycoMore, and Acifix, addressing vital wants in cardiology, hepatology, diet, and diabetology, marking a strategic enlargement of its branded formulations enterprise in India.

It additionally launched Empamore in March, reflecting a powerful push in the direction of innovation-driven, specialty-focused therapeutics. Moreover, the corporate has additionally disclosed of reaching Rs 1,000 crore, from Rs 325 crores, over the subsequent 5 years.

Additionally learn: Inventory below ₹200 skyrockets 13% after ₹752 Cr partnership with Govt of Singapore Funding Corp

Product Highlights

Ticapen (Ticagrelor 60mg/90mg) is a cheap, clinically confirmed antiplatelet remedy for ACS, Angina, and MI. Produced in USFDA-approved services, it boasts a particular 4×14 patient-friendly pack with Day/Night time compliance markers and high-quality matte foil packaging, offering common entry at a aggressive value.

UdoFix (Ursodeoxycholic Acid 150/300mg) redefines liver well being with 98.23% higher dissolution. Made in a USFDA-approved plant with anti-counterfeit Holosec packaging, its value is ₹39.9/tab, offering a cost-effective substitute to market leaders.

LycoMore Syrup pairs Lycopene with key nutritional vitamins and minerals to reinforce immunity and restoration. In a glass bottle for larger shelf life, it’s straightforward on the palate with a nutrient-dense components, guaranteeing affected person comfort and adherence.

Acifix Raft Suspension presents speedy, focused aid for GERD, reflux, and heartburn with a swift-acting raft mechanism and novel paan taste, enhancing affected person compliance for optimum acid management.

In regards to the firm

Morepen Laboratories manufactures and markets prescribed drugs reminiscent of APIs, well being gadgets, and OTC merchandise in India and abroad. It gives remedy for ailments reminiscent of allergic reactions, diabetes, and hypertension, and diagnostic merchandise reminiscent of thermometers and glucose meters. Dr. Morepen’s portfolio consists of merchandise for fever, ache, acidity, and total well-being.

Written by Satyajeet Mukherjee

Disclaimer

The views and funding suggestions expressed by funding consultants/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer aren’t answerable for any losses prompted because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.